XML 30 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-based compensation cost
Total estimated stock-based compensation expense for employees and non-employees, related to all of the the Company's stock-based awards, was comprised as follows:


Three Months Ended

March 31,

2015

2014

 (in thousands)
Cost of revenue
$
218

 
$
30

Selling and marketing
144

 
120

Product development
205

 
206

General and administrative
758

 
693

Total stock-based compensation
$
1,325

 
$
1,049

Stock activity and total number of shares available for grant
The following table presents the stock activity and the total number of shares available for grant as of March 31, 2015:
 
(in thousands)
Balance at December 31, 2014
443

Options granted
(85
)
Forfeited/Expired shares added back
78

Balance at March 31, 2015
436

Stock option activity
 
Options Outstanding
 
Number of Shares Underlying Outstanding Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
 
Aggregate Intrinsic Value
 
 
 
 
 
 (In years)
 
 
Outstanding at December 31, 2014
6,588,097

 
6.95
 
6.96
 
1,327,366

Granted
85,000

 
3.16
 
 
 
 
Exercised
(104,560
)
 
1.39
 
 
 
 
Forfeited
(149,535
)
 
9.11
 
 
 
 
Outstanding at March 31, 2015
6,419,002

 
6.94
 
6.53
 
259,781

Vested and expected to vest at March 31, 2015
6,253,297

 
6.90
 
6.46
 
259,781

Exercisable at March 31, 2015
3,589,031

 
5.86
 
4.99
 
259,781

Schedule of weighted-average assumptions
The following are assumptions for the three months ended March 31, 2015.
Expected term (in years)
6.1
Risk-free interest rate
1.5% - 1.8%
Expected volatility
46.3% - 46.5%
Dividend rate
0%
Restricted stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock option activity
 
Shares
 
Weighted Average Grant Date Fair Value Per Share
Nonvested restricted stock at December 31, 2014
6,396

 
$
15.63

Granted

 

Nonvested restricted stock at March 31, 2015
6,396

 
15.63